Research desk · GLUC · OTC
GLUC Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
GLUCOSE HEALTH, INC. · Medicinal Chemicals & Botanical Products
GLUCOSE HEALTH, INC. financial statements, chart, and peer compare from SEC filings.
GLUCOSE HEALTH, INC. (GLUC) operates in Medicinal Chemicals & Botanical Products.
- Market cap
- $1.43M
- P/E
- —
- Op. margin
- -30.19%
- Profit margin
- -10.43%
- FCF margin
- -176.58%
- ROE
- 1.83%
Related Health Care stocks: STME stock financials · SMMT stock financials · INBX stock financials · VSBC stock financials · TSHA stock financials
GLUC financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
GLUC stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
GLUC stock peer headlines
Yahoo Finance RSS for GLUC and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
GLUC stock price chart
Overlays follow the Compare table.
GLUC stock — research snapshot
Screen strengths and watchouts for GLUC stock from the latest Misprise snapshot.
Strengths
- Revenue CAGR 3Y 1,018.3% — durable top-line compound.
- EPS CAGR 5Y 49.6% — earnings compounding.
- Debt/equity -0.40 — leverage looks manageable.
Watchouts
- ROA -29.5% — muted asset returns.
- ROE 1.8% — soft equity returns.
- Operating margin -30.2% — thin operating cushion.
- Negative profit margin — earnings quality needs scrutiny.
- Negative FCF margin — cash generation is under pressure.
- Rev CAGR 5Y —
- Rev CAGR 3Y 1,018.3%
- EPS CAGR 5Y 49.6%
- EPS CAGR 3Y -68.7%
- FCF CAGR 5Y 11.0%
- FCF CAGR 3Y -33.2%
GLUC stock FAQs
Short answers for GLUC stock — statements, sector, and how this page is meant to be used.
What is GLUC stock?
GLUCOSE HEALTH, INC. (GLUC) operates in Medicinal Chemicals & Botanical Products. GLUC stock sits in Health Care (Medicinal Chemicals & Botanical Products), listed on OTC.
Where can I find GLUCOSE HEALTH, INC. financial statements?
GLUCOSE HEALTH, INC. financial statements — income statement, balance sheet, and cash flow — are on this GLUC stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to GLUC stock?
This page is a research snapshot of GLUCOSE HEALTH, INC. (GLUC) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the GLUC stock price?
The live chart on this GLUC stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is GLUC stock in?
GLUCOSE HEALTH, INC. is classified in Medicinal Chemicals & Botanical Products, inside the Health Care sector, and trades on OTC. This page is a research snapshot, not a full company profile.
How do I read GLUC financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the GLUC statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the GLUC income statement, balance sheet, and cash flow?
On this GLUC stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for GLUC stock?
GLUC stock currently scores 0/100 (Watch / incomplete (<60)). GLUCOSE HEALTH, INC. scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the GLUC comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this GLUC page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on GLUC stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is GLUC stock a buy?
No recommendation either way. This GLUC stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell GLUCOSE HEALTH, INC..